Health assessment programmay resultfrom cardiovascular disease research diabetes permanently in as 11 days
trigger fat lossresultingin considerable health advantages for people with type 2 diabetes or prediabetes
and cause weight lossresultingin significant health and fitness benefits for people who have type 2 diabetes or prediabetes
Obesityleadsto many health outcomes such as type 2 diabetics , cardiovascular disease , and stroke
trigger fat lossresultingin considerable health advantages for individuals with type 2 diabetes or prediabetes
Why its used , metformin oral tablets are used to metformin long term side effects treat high blood sugar levelscausedmetformin long term side effects by type 2 diabetes
the multifactorial approachleadsto improved cardiovascular benefits in individuals who have type 2 diabetes
lead to Extra fat reductionresultingin sizeable health Advantages for individuals with type 2 diabetes or prediabetes
a thorough examination of the multifactorial approachleadsto improved cardiovascular benefits in individuals who have type 2 diabetes
all types of exerciseresultedin multiple health benefits for people with type 2 diabetes
The diet lead to fat reductionresultingin significant health benefits for people with prediabetes or type 2 diabetes
cause fat lossleadingto significant health benefits for people with type 2 diabetes or prediabetes
we believewill resultin better outcomes for people with Type 2 Diabetes
cause fat reductionresultingin significant health benefits for people with type 2 diabetes or prediabetes
a continued obesitymay leadto poor cardiovascular outcomes ... and type 2 diabetes
NU2058 supplierdiscoveredin healthy people who later continue to build up type 2 diabetes
cause weight lossresultingin considerable health benefits for individuals with type 2 diabetes or prediabetes
good glycaemic control ... only one factorinfluencesoutcomes in people with type 2 diabetes
other factorsmay influenceType 2 diabetes risk ... including cardiorespiratory fitness level
lead to Body fat lossleadingto sizeable health and fitness Added benefits for those with type 2 diabetes or prediabetes
result in extra fat lossultimately causingsignificant health and fitness benefits for those who have type 2 diabetes or prediabetes
the components of diabetic dyslipidaemiacontributeto the increased cardiovascular risk seen in type 2 diabetes
by Zealand Pharma(passive) discovered bya once - daily GLP-1 agonist for the treatment of Type 2 diabetes
cause fat reductionleadingto significant health and fitness benefits for those who have type 2 diabetes or prediabetes
one mechanism by whichleadsto poorer cardiovascular outcomes in type 2 diabetes
obesity in most cases(passive) is caused byType 2 diabetes , which is itself a strong risk factor for cardiovascular disease
Other possible mechanisms behind this association ... chemotherapy agents , such as L - asparaginase , total body irradiation , and immunosuppressive agents like calcineurin inhibitors , and tamoxifenmay causehyperglycemia and subsequent risk for type 2 diabetes
basal insulinpromptedon cardiovascular outcomes in type 2 diabetes
these types of dietscan ... causelong term remission in type 2 diabetes
cause fat lossresultingin significant health benefits for those who have type 2 diabetes or prediabetes
the likelihoodwill resultin long - term remission of type 2 diabetes
Gastric bypass surgery in the Brisbane areacan resultin long - term remission from type 2 diabetes
cause fat reductionresultingin significant health benefits for those who have type 2 diabetes or prediabetes
significant weight losscould resultin complete remission from type 2 diabetes
insulinespecially designedfor type 2 diabetes that is injected only once daily
type?Which lipid abnormalitiescontributeto cardiovascular risk in type 2 diabetes mellitus
Vulnerable Populationsdesignedonce you have type 2 diabetes
to an increased risk of bladder cancercould leadto an increased risk of bladder cancer
in disability and early deathcan resultin disability and early death
This study(passive) was carefully designedThis study
a patient to develop high blood sugar levelscausesa patient to develop high blood sugar levels
in cognitive impairmentmay resultin cognitive impairment
deficient beta cells that produce insulin in the pancreascausingdeficient beta cells that produce insulin in the pancreas
from either the body not producing enough insulin or the cellsresultsfrom either the body not producing enough insulin or the cells
in serious complicationscan resultin serious complications
when the body 's insulin does not work effectivelyresultswhen the body 's insulin does not work effectively
to an improvement of whole - body energy homeostasisleadingto an improvement of whole - body energy homeostasis
in cognitive impairmentmay resultin cognitive impairment
to inconsistent resultshave ledto inconsistent results
to reduced CVD event rates compared with other antidiabetic medicationsleadsto reduced CVD event rates compared with other antidiabetic medications
to deathleadingto death
to a label expansion in October 2018 to include the prevention of MI , stroke , and death among patients with type 2 diabetes who have established cardiovascular diseaseledto a label expansion in October 2018 to include the prevention of MI , stroke , and death among patients with type 2 diabetes who have established cardiovascular disease
long - term health problemscan causelong - term health problems
lowmay causelow
to heart disease , kidney and nerve disorders , loss of vision , and other problemscan leadto heart disease , kidney and nerve disorders , loss of vision , and other problems
The team(passive) is composedThe team
T2DcontributesT2D
to heart attacks , congestive heart failure and other fatal cardiovascular events in seven individualsledto heart attacks , congestive heart failure and other fatal cardiovascular events in seven individuals